USFDA approves Sun Pharma for New Drug Application

Sun Pharma has got approval from USFDA for an Abbreviated New Drug Application to display a common version of Venlafaxine Hydrochloride Extended Release tablets. Moreover, these tablets are similar to Osmotica’s Venlafaxine Hydrochloride Extended Release tablet which has 37.5mg (base), 75mg (base), and 150mg (base).

0 comments: